Topline Capital Management’s Nutex Health NUTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.14M Sell
41,764
-136,036
-77% -$17.2M 1.85% 12
2026
Q1
$16.9M Sell
177,800
-497,694
-74% -$61M 2.79% 12
2025
Q4
$111M Buy
675,494
+118,927
+21% +$15.8M 10.06% 2
2025
Q3
$57.5M Buy
556,567
+247,436
+80% +$24.3M 9.89% 3
2025
Q2
$38.5M Buy
309,131
+129,418
+72% +$16.7M 6.6% 6
2025
Q1
$8.45M Buy
179,713
+173
+0.1% +$8.44K 1.93% 14
2024
Q4
$5.69M Buy
+179,540
New +$5.12M 1.08% 18

Other funds holding NUTX

Topline Capital Management's NUTX Position: Q2 2026 in Review

Topline Capital Management reduced its Nutex Health (NUTX) stake by 77% in Q2 2026, selling an estimated $17.2M and leaving 41,764 shares worth $7.14M. The position accounts for 1.85% of the portfolio, ranked #12.

Topline Capital Management first reported a position in NUTX in Q4 2024 and has held it in 7 quarters since. The position peaked at $111M in Q4 2025. 154 funds tracked by Wall St. Rank hold NUTX as of Q2 2026.

  • Topline Capital Management held 41,764 shares of Nutex Health worth $7.14M as of Q2 2026.
  • Topline Capital Management sold 136,036 Nutex Health shares in Q2 2026, an estimated $17.2M.
  • Nutex Health made up 1.85% of Topline Capital Management's portfolio in Q2 2026, its #12 holding.
  • Topline Capital Management first reported a position in Nutex Health in Q4 2024 and has held it in 7 quarters since.
  • Topline Capital Management's Nutex Health position peaked at $111M in Q4 2025.
  • 154 funds tracked by Wall St. Rank held Nutex Health as of Q2 2026.

Based on Topline Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.